Exploring health equity in cognitive aging and Alzheimer's disease.
Center for Health Equity in Cognitive Aging - Joining Population Science and Health Promotion (CHECA)
This study is all about finding better ways to support people at risk for Alzheimer's and their caregivers, especially in different communities, by creating helpful resources and training new scientists to tackle these challenges together.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10907035 on NIH RePORTER |
What this research studies
This research focuses on understanding and addressing the disparities in Alzheimer's disease and related dementias (ADRD) among diverse populations. It aims to build a robust research infrastructure that supports behavioral and social research, while also training early-career scientists in this field. The project will develop and test health-promoting resources tailored for adults at risk for ADRD and their caregivers, emphasizing the importance of environmental and sociocultural factors. By integrating population science with health promotion, the research seeks to innovate approaches to reduce ADRD inequities.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults aged 21 and older who are at risk for Alzheimer's disease or related dementias, as well as their caregivers.
Not a fit: Patients who are not at risk for Alzheimer's disease or related dementias may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health resources and interventions that better support individuals at risk for Alzheimer's disease and their families.
How similar studies have performed: Previous research has shown success in addressing health disparities in dementia care, indicating that this approach has potential for meaningful impact.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Muramatsu, Naoko — University of Illinois at Chicago
- Study coordinator: Muramatsu, Naoko
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.